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Abstract
KSHV is etiologically associated with Kaposi’s sarcoma (KS), an angioproliferative endothelial cell malignancy.
Macropinocytosis is the predominant mode of in vitro entry of KSHV into its natural target cells, human dermal
microvascular endothelial (HMVEC-d) cells. Although macropinocytosis is known to be a major route of entry for many
viruses, the molecule(s) involved in the recruitment and integration of signaling early during macropinosome formation is
less well studied. Here we demonstrate that tyrosine phosphorylation of the adaptor protein c-Cbl is required for KSHV
induced membrane blebbing and macropinocytosis. KSHV induced the tyrosine phosphorylation of c-Cbl as early as 1 min
post-infection and was recruited to the sites of bleb formation. Infection also led to an increase in the interaction of c-Cbl
with PI3-K p85 in a time dependent manner. c-Cbl shRNA decreased the formation of KSHV induced membrane blebs and
macropinocytosis as well as virus entry. Immunoprecipitation of c-Cbl followed by mass spectrometry identified the
interaction of c-Cbl with a novel molecular partner, non-muscle myosin heavy chain IIA (myosin IIA), in bleb associated
macropinocytosis. Phosphorylated c-Cbl colocalized with phospho-myosin light chain II in the interior of blebs of infected
cells and this interaction was abolished by c-Cbl shRNA. Studies with the myosin II inhibitor blebbistatin demonstrated that
myosin IIA is a biologically significant component of the c-Cbl signaling pathway and c-Cbl plays a new role in the
recruitment of myosin IIA to the blebs during KSHV infection. Myosin II associates with actin in KSHV induced blebs and the
absence of actin and myosin ubiquitination in c-Cbl ShRNA cells suggested that c-Cbl is also responsible for the
ubiquitination of these proteins in the infected cells. This is the first study demonstrating the role of c-Cbl in viral entry as
well as macropinocytosis, and provides the evidence that a signaling complex containing c-Cbl and myosin IIA plays a
crucial role in blebbing and macropinocytosis during viral infection and suggests that targeting c-Cbl could lead to a block
in KSHV infection.
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Introduction
KSHV is etiologically associated with Kaposi’s sarcoma (KS),
the most common AIDS related malignancy, as well as with two
lymphoproliferative diseases, primary effusion lymphoma (PEL)
and multicentric Castleman’s disease [1,2]. KSHV infects a variety
of target cells both in vivo and in vitro. Entry into the target cells is
the most crucial step in the establishment of a successful infection
for all viruses. KSHV utilizes different modes of endocytosis to
enter different target cells in vitro [3]. For example, KSHV enters
human foreskin fibroblasts (HFF) via clathrin mediated endocy-
tosis and enters HMVEC-d cells via macropinocytosis [3,4,5].
During the early stages of infection of HMVEC-d cells, KSHV
forms a multi-molecular complex with host cell heparan sulfate,
integrins (a3b1, aVb3 and aVb5) and transporter protein xCT
with the subsequent induction of overlapping signal cascades [3].
Our studies show that KSHV induces a complex set of signaling
molecules that are involved in diverse biological functions to
regulate the various aspects of KSHV endocytosis including
internalization, trafficking in the cytoplasm and nuclear delivery
[3]. KSHV activates FAK, Src, PI3-K, Rho-GTPases and
cytoskeleton rearrangement which are all critical for entry of
virus [6,7,8,9]. KSHV also activates other downstream molecules
such as PKC-f, MEK, ERK1/2 and NFkB which are essential for
viral gene expression [6,7,8,9].
The Cbl family of adaptor proteins include three mammalian
isoforms, c-Cbl, Cbl-b and Cbl-c or Cbl-3 [10,11]. Cbl proteins play
important roles in signal transduction as negative regulators by
mediating the ubiquitinilation and down-regulation of proteins while
it acts as a positive regulator through their scaffold function in
assembling signaling complexes [10,11]. c-Cbl has been shown to
bind to several molecules critical in signal transduction [10,11].
Tyrosine phosphorylation of c-Cbl has been shown to be crucial for c-
Cbl mediated adaptor functions in most circumstances [11,12,13].
However, the adaptor functions of c-Cbl and a c-Cbl mediated
signaling pathway during virus infection has not been demonstrated.
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infection of many viruses including KSHV. Macropinocytosis is an
actin dependent membrane associated process which involves
recruitment and integration of several signaling molecules necessary
forcytoskeletalrearrangementandmembraneremodeling.However,
there is little information about the molecules involved in the
recruitment and integration of signaling during macropinosome
formation. Even though c-Cbl has been shown to recruit and link
different signaling molecules in a signaling pathway, a direct role for
c-Cbl in the process of macropinocytosis has not been established yet.
Here we identified that c-Cbl is involved in KSHV entry and
critical for triggering the macropinocytic event. Our data provide
evidence that the interaction between c-Cbl and myosin IIA, a
motor protein that binds to the proline rich domain of c-Cbl,
regulates macropinocytosis of KSHV. This study on the functional
organization of the c-Cbl and myosin IIA complex and its effect on
viral entry provide an important insight into understanding the
role of c-Cbl in virus infection.
Materials and Methods
Cells and virus
HMVEC-d cells (CC-2543; Clonetics, Walkersville, Md) were
grown in endothelial cell medium (EBM2; Cambrex, Walkersville,
MD). Induction of the KSHV lytic cycle in BCBL-1 cells,
supernatant collection, and virus purification procedures were
described previously [14]. KSHV DNA was extracted from the
virus, and the copies were quantitated by real-time DNA PCR
using primers amplifying the KSHV ORF 73 gene as described
previously [15].
Generation of HMVEC-d cells expressing shRNA
A pool of lentivirus shRNA specific for human c-Cbl and non-
specific control shRNA were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). HMVEC-d cells were transduced
with control lentivirus shRNA and c-Cbl lentivirus shRNA
according to the manufacturer’s instructions and selected by
puromycin hydrochloride (10 mgm l
21; Santa Cruz Biotechnology).
Antibodies and reagents
The following antibodies were used: mouse anti-c-Cbl, mouse
anti-phospho Cbl 700 (phosphorylated at Tyr700), and mouse
anti-p85 (PI-3K) antibodies (BD Transduction Laboratories, San
Diego, CA); anti-phospho MLC II, anti-phospho Cbl 731, anti-
phospho Cbl 774 (phosphorylated at Tyr731 and Tyr774), isoform
specific anti-myosin II heavy chain antibodies myosin IIA, IIB and
IIC (Cell Signaling Technology, Danvers, MA); mouse anti-
phospho tyrosine (4G10 clone; Millipore, Temecula, CA); mouse
anti-tubulin, mouse anti-beta actin antibodies (Sigma, St Louis,
MO); rabbit anti-lamin B (Abcam, Cambridge, MA); rabbit anti-
HA (Zymed, Invitrogen, Carlsbad, CA); mouse anti-ubiquitin
(P4D1), mouse ant-GFP, mouse anti-GST (Santa Cruz, CA);
rabbit anti-gB and mouse anti-gpK8.1A antibodies were created in
our laboratory[16,17]; anti-goat, anti-rabbit and anti-mouse
antibodies linked to horseradish peroxidase (KPL Inc., Gaithers-
burg, Md.); DAPI, rhodamine conjugated dextran, Alexa 594 or
Alexa 488 conjugated phalloidin and anti-rabbit and anti-mouse
secondary antibodies conjugated to Alexa 488, Alexa 594
(Invitrogen); protein A and G–Sepharose CL-4B beads (Amer-
sham Pharmacia Biotech, Piscataway, NJ); blebbistatin, U0126
(Calbiochem, La Jolla, CA); TPA, LY294002 (Sigma).
Measurement of KSHV entry by real-time DNA PCR
Unless stated otherwise, cells were infected with KSHV at 10
DNA copies (multiplicity of infection [MOI]) per cell at 37uC.
Entry was measured by infecting the cells with KSHV for 30 min.
The cells were washed with HBSS to remove the unbound virus,
treated with 0.25% trypsin-EDTA for 5 min at 37uC to remove
the bound but non-internalized virus, and washed. Cells were
recovered by centrifugation and total DNA was isolated from
infected or uninfected cells using a DNeasy kit (QIAGEN,
Valencia, CA) as described previously [15]. To calculate percent
of inhibition of KSHV entry, internalized KSHV DNA was
quantitated by amplification of the ORF73 gene by real-time
DNA PCR [15]. The KSHV ORF73 gene cloned in the pGEM-T
vector (Promega) was used for the external standard. The cycle
threshold (Ct) values were used to generate the standard curve and
to calculate the relative copy numbers of viral DNA in the samples.
Percentage inhibition was calculated by considering the ORF73
copy numbers in untransduced cells as 100%.
KSHV gene expression measurement by real-time RT-PCR
Total RNA was prepared from infected or uninfected cells using
an RNeasy kit (QIAGEN) as described previously [15]. To
quantitate viral gene expression, isolated RNA was subjected to
ORF73 and ORF50 RNA expression by real-time reverse
transcription (RT)-PCR using gene specific real-time primers
and specific TaqMan probes [15]. The relative copy numbers of
the transcripts were calculated from the standard curve plotted
using the Ct values for different dilutions of in vitro-transcribed
transcripts. These values were normalized to each other using the
values of the GAPDH control reactions. Percentage inhibition was
calculated by considering ORF73 and ORF50 gene expression in
untransduced cells as 100%.
Western blotting
Cells were lysed in RIPA buffer (15 mM NaCl, 1 mM MgCl2,
1 mM MnCl2, 2 mM CaCl2, 2 mM phenylmethylsulfonyl
fluoride, and protease inhibitor mixture (Sigma)) and centrifuged
at 12,000 rpm at 4uC for 15 min. Lysates were normalized to
equal amounts of protein and the proteins were separated by 7.5–
12.5% gradient SDS-PAGE, transferred to nitrocellulose and
probed with the indicated primary antibodies. Detection was by
incubation with species-specific HRP-conjugated secondary anti-
bodies. Immunoreactive bands were visualized by enhanced
chemiluminescence (Pierce, Rockford, IL) according to the
Author Summary
KSHV is etiologically associated with Kaposi’s sarcoma (KS),
the most common AIDS related neoplasm. The first key
step in KSHV infection is its initial contact with target cells
and entry. While it is known that KSHV uses macropino-
cytosis for its infectious entry into its natural target cells,
HMVEC-d cells, we know little about the molecule(s)
involved in this event. Here, we show that the adaptor
protein c-Cbl plays a major role in regulating bleb
associated macropinocytosis of KSHV. The results demon-
strate that c-Cbl protein functions as an adaptor for the
myosin II hexameric complex in macropinocytic events.
Knocking down c-Cbl by shRNA induces defects in myosin
II dependent blebbing and KSHV entry, indicating that c-
Cbl uses myosin II to coordinate signaling pathways,
resulting in bleb formation and bleb retraction. This work
provides a clear understanding of the role of c-Cbl in the
recruitment and integration of signaling molecules around
the macropinosome during virus infection, and identifies
potential targets to intervene in KSHV infection.
c-Cbl Regulates KSHV Macropinocytosis
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quantitated using the FluorChem FC2 and Alpha-Imager Systems
(Alpha Innotech Corporation, San Leonardo, CA).
Immunoprecipitation
Two hundred micrograms of cell lysates prepared as described
in the above section were incubated for 2 h with immunoprecip-
itating antibody at 4uC, and the immune complexes were captured
by protein A or G-Sepharose. The samples were tested by Western
blot with specific primary and secondary antibodies.
Mass spectrometry and protein analysis
HMVEC-d cells were infected with KSHV for different time
points. The samples were resolved on an SDS-PAGE gel and the
gel was stained with Coomassie blue. The bands of interest were
excised, digested with trypsin, separated by reverse phase nano-
chromatography and analyzed by mass spectrometry.
Immunofluorescence and microscopy
Immunofluorescence assay was performed using HMVEC-d cells
seeded on 8 well chamber slides (Nalge Nunc International).
Infected and uninfected cells were fixed with 3% paraformaldehyde
for 15 min, permeabilized with 0.2% Triton X-100, and blocked
with Image-iTFX signal enhancer (Invitrogen). The cells were then
immunostained with primary antibodies against the specific
proteins, followed by fluorescent dye-conjugated secondary anti-
bodies. For colocalization with dextran and transferrin, cells were
incubated with the fluid-phase marker dextran Texas Red (40 kD,
0.5 mg ml
21; Invitrogen) or Alexa 594 transferrin (35 mgm l
21;
Invitrogen) at 37uC in the presence or absence of KSHV followed
by immunostaining with the appropriate antibodies. Cells were
imaged with a Nikon fluorescence microscope equipped with a
Metamorph digital imaging system. DIC (Differential Interference
Contrast) images were acquired with objectives equipped with DIC
optics. For confocal analysis, the Olympus Fluoview 300 fluores-
cence confocal microscope was used for imaging, and analysis was
performed using Fluoview software (Olympus, Melville, NY). All
experiments were performed at least three times.
Quantitative analysis of dextran uptake
HMVEC-d cells, incubated with dextran Texas Red (0.5 mg
ml
21, 40 kD; Invitrogen) and KSHV for 30 min, were washed
twice in HBSS. To remove surface bound dextran, cells were
treated with 0.25% trypsin-EDTA and the cells were harvested.
Quantitative analysis of dextran uptake was determined by
counting the number of cells stained positive for dextran under
immunofluorescence microscope. At least 10 different microscopic
fields of 50 cells each were counted for each experiment and the
results displayed as percentage of dextran positive cells.
Flow cytometry analysis
Flow cytometry analysis was used to quantify the uptake of dextran
during KSHV internalization in control shRNA and c-Cbl shRNA
transduced cells. Cells were incubated with 500 mgm l
21 FITC-
dextran in the presence or absence of virus at 37uC for 30 min. The
cells were washed, harvested using trypsin EDTA, fixed and analyzed
by flow cytometry. Mean fluorescence intensity was determined using
a Becton Dickinson FACS system and CellQuest software. Cells
incubated with dextran alone were used as controls.
Plasmids and transfection
HeLa cells (ATCC CCL-2) were cultured in DMEM containing
10% fetal bovine serum. Wild type, mutants and deletion
constructs of c-Cbl, c-Cbl C-terminal domain encompassing
PRD (Cbl-C) and c-Cbl N-terminal domain (Cbl-N) constructs
were generously provided by Dr. Hamid Band [18] (Eppley
Institute for Cancer and Allied Diseases, University of Nebraska
Medical Center). Cells were transiently transfected with wild type,
mutants and deletion constructs. Transfection was performed
using 5 mg of plasmid DNA, lipofectamine 2000 (Invitrogen), and
Opti-MEM medium (Invitrogen) according to the manufacturer’s
instructions. After transfection, cells were cultured for 48 h. Cells
were then serum starved for 4 h and stimulated with TPA (100 ng
ml
21)a t3 7 uC for 5 min. Lysis was performed in RIPA buffer plus
protease inhibitors. The cell lysate was used for immunoprecip-
itation and immunoblotting.
GST pull-down assay
E. coli BL21 (DE3) cells were transformed with pGEX4T.1
GST-Cbl C (Cbl residues 358–906) plasmids which encode regions
encompassing the C-terminal PRD domain of c-Cbl and
pGEX4T.1 GST-Cbl N which encodes the N-terminal region of
c-Cbl. Expression of the GST-Cbl fusion proteins was induced
with IPTG (isopropyl-D-1-thiogalactopyranoside) 1 mM for 3 h at
37uC. The bacterial lysates (500 mg) were incubated with
glutathione-sepharose beads (GE Healthcare, U.K.) for 2 h at
4uC. The beads were washed with lysis buffer three times. 293T
cells were transiently transfected with 2 mg pEGFP C3 myosin IIA
plasmids (Addgene). After 48 h of transfection, cells were lysed in
RIPA buffer and 500 mg of the lysates were incubated with the
glutathione-Sepharose beads bound with the GST-Cbl fusion
proteins. The beads and the bound proteins were collected by
centrifugation, washed and the interaction of GST-Cbl with
myosin IIA was analyzed by SDS-PAGE and Western blotting
using anti-GFP antibody.
Determination of blebbing
HMVEC-d cells infected with KSHV for 5 min were fixed and
stained with DAPI. DIC images were acquired and the cells
presenting blebs or no blebs were counted visually. At least 10
random microscopic fields per experiment were counted and
expressed as a proportion of the total number of DAPI stained
cells.
Cell membrane preparation
Infected and uninfected cells were washed three times with
HBSS and lysed in homogenization buffer (250 mM sucrose,
20 mM HEPES, 10 mM KCL, 1 mM EDTA, 1 mM EGTA and
protease inhibitors). The homogenate was subjected to centrifu-
gation at 3,000 rpm for 5 min. Post-nuclear supernatant was
centrifuged at 8,000 rpm for 5 min at 4uC. The supernatant was
again centrifuged at 40,000 rpm for 1 h at 4uC, and the
supernatant and the pellet were considered the cytosolic and the
membrane fractions, respectively. The membrane pellet was
solubilized using RIPA buffer and used for Western blot.
Results
KSHV infection induces tyrosine phosphorylation of c-Cbl
and association of c-Cbl with PI3-K
To determine whether c-Cbl and the c-Cbl mediated signaling
pathway play roles in KSHV infection, we first examined the early
tyrosine phosphorylation kinetics of c-Cbl in KSHV infected cells.
HMVEC-d cells infected with KSHV induced rapid tyrosine
phosphorylation of c-Cbl, which was detectable as early as 1 min
post-infection (p.i.), reaching maximum levels at 5 min (4.1-fold),
followed by a decrease which was constent for as much as 30 min
c-Cbl Regulates KSHV Macropinocytosis
PLoS Pathogens | www.plospathogens.org 3 December 2010 | Volume 6 | Issue 12 | e1001238Figure 1. KSHV infection induces tyrosine phosphorylation of c-Cbl and association of c-Cbl with PI3-K. (a) KSHV infection induces
tyrosine phosphorylation of c-Cbl. HMVEC-d cells were left uninfected or infected with KSHV for the indicated time points after serum starvation.
Tyrosine phosphorylation of c-Cbl was determined by immunoprecipitating with anti-c-Cbl and Western blotting with anti-phosphotyrosine antibody
4G10. Cells treated with 10% FBS for 10 min were used as positive control. As a negative control, cells were infected for 10 min with KSHV pre-
incubated with heparin (50 mgm l
21) for 1 h at 37uC. Band intensities (middle panel) were assessed as described in the methods and expressed as
increased fold tyrosine phosphorylation of c-Cbl over uninfected cells. Bottom panel shows the blot reprobed with anti-c-Cbl antibody. (b) c-Cbl
associates with PI3-K in the infected cells. Uninfected or cells infected with KSHV for different time points were lysed and immunoprecipitated with
anti-c-Cbl and Western blotted with anti-p85 (PI-3K) antibody. Cells infected for 10 min with heparin treated virus were used as specificity control.
Bottom panel shows the blot reprobed with anti-c-Cbl antibody. (c) c-Cbl colocalizes with PI3-K in the infected cells. HMVECd cells infected with KSHV
for 5 min were immunostained with anti-c-Cbl and anti-PI3-K p85 antibody and analyzed by confocal microscopy. Arrows indicate colocalization of c-
Cbl-with PI3-K p85. ERK staining showing no colocalization with c-Cbl was used as specificity control. (d) Effect of PI3-K and ERK1/2 inhibitors on c-Cbl
phosphorylation. HMVEC-d cells either left untreated or pre-treated with 50 mM LY294002 (LY) or 10 mM U0126 for 1 h were infected with KSHV for
10 min. Uninfected and infected cell lysates were immunoprecipitated with anti-c-Cbl and Western blotted with anti-phospho Cbl antibody.
doi:10.1371/journal.ppat.1001238.g001
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is specifically induced by KSHV, cells were infected with KSHV
pre-incubated with heparin. Heparin is known to block the binding
of KSHV to the target cells [19]. Compared to the untreated virus,
heparin treated virus considerably reduced the phosphorylation of
c-Cbl (Figure 1a) which demonstrated the specificity of KSHV
induced c-Cbl phosphorylation. The efficient tyrosine phosphory-
lation of c-Cbl is suggestive of the possible involvement of a c-Cbl
mediated signaling pathway in KSHV infection.
We next investigated the link between c-Cbl phosphorylation
and other signaling molecules activated during KSHV infection. It
is well documented that the interaction of KSHV glycoproteins
with integrins and other cellular receptors activate FAK and the
downstream molecules Src and PI3-K [7,9,14,20,21]. c-Cbl has
been shown to form a complex with PI3-K p85 in the integrin
mediated signaling pathway [12]. We therefore examined whether
the association of PI3-K with c-Cbl occurred during KSHV
infection. KSHV infection led to an increase in the interaction of
c-Cbl with PI3-K p85 in a time dependent manner (Figure 1b). To
verify that the c-Cbl-PI3-K interaction is specifically induced by
virus, cells were infected with heparin treated virus which notably
decreased the association of c-Cbl with PI3-K (Figure 1b). The c-
Cbl-PI3-K association was further confirmed by confocal analysis
(Figure 1c). Consistent with previous studies [13], our results
demonstrated that activated c-Cbl leads to the association of c-Cbl
with PI3-K.
Previous studies have shown that ERK1/2 is activated during
KSHV infection and is a key signaling molecule implicated in viral
gene expression [22]. To examine whether an ERK1/2 associated
pathway is involved in c-Cbl mediated signaling, we investigated
the association of ERK1/2 with c-Cbl in KSHV infected cells. No
colocalization was observed between ERK1/2 and c-Cbl
(Figure 1c) which suggested that the ERK associated pathway is
not involved in c-Cbl mediated signaling in KSHV infected cells.
Taken together, our data suggests that a signaling complex which
contains c-Cbl and PI3-K but not ERK1/2 is involved in the
integrin mediated signaling pathway of KSHV infection.
To further demonstrate the relationship between the interaction
of c-Cb1 with PI3-K but not with ERK1/2, we studied the effect
of PI3-K and ERK1/2 inhibitors in KSHV induced c-Cbl
phosphorylation. HMVEC-d cells pretreated with the PI3-K
inhibitor, LY294002, and the ERK1/2 inhibitor, U0126 were
infected with KSHV for 10 min and the lysates were analyzed for
c-Cbl phosphorylation. KSHV induced c-Cbl phosphorylation
was abolished by the PI3-K inhibitor LY294002, whereas the
ERK1/2 inhibitor U0126 did not show any inhibition on c-Cbl
phosphorylation (Figure 1d). The failure of ERK1/2 inhibitor to
abolish c-Cbl phosphorylation confirmed that ERK1/2 is not
associated with c-Cbl induction in KSHV infected cells.
c-Cbl shRNA inhibits KSHV entry and infection
We next used c-Cbl lentivirus encoding shRNAs to knockdown
c-Cbl activity in HMVEC-d cells (c-Cbl shRNA cells) to analyze
the functions of c-Cbl in KSHV infected cells. The c-Cbl specific
shRNA inhibited 90% of c-Cbl expression as detected by Western
blotting with antibodies to c-Cbl (Figure S1a). Untransduced,
control shRNA and c-Cbl shRNA transduced cells were infected
with KSHV for 2 and 24 h, and viral gene expression was
determined by real-time RT-PCR analysis. Compared with
control cells, c-Cbl shRNA transduced cells showed about 60–
70% inhibition of the latency associated ORF 73 gene (Figure 2a)
and 70–80% inhibition of the lytic switch ORF 50 gene (Figure 2b)
expression.
We next determined whether the inhibition of viral-gene
expression by c-Cbl shRNA was due to a blockage at the entry
stage of the virus. To determine c-Cbl’s role in KSHV entry,
internalization of viral DNA was determined by measuring viral
ORF 73 DNA copy numbers by real-time DNA PCR. We
observed ,65% inhibition of KSHV entry in c-Cbl shRNA cells
compared to control cells (Figure 2c). Internalized KSHV ORF 73
DNA copy numbers and ORF 50 and ORF 73 RNA copy
numbers are shown as histograms in supplementary Figure S1.
Taken together, these studies demonstrated that the decreased
Figure 2. c-Cbl shRNA inhibits KSHV entry and infection. (a and
b) KSHV gene expression in c-Cbl ShRNA transduced cells. Untrans-
duced, control shRNA and c-Cbl shRNA transduced HMVEC-d cells were
infected with KSHV. At 2 and 24 h post infection, cells were harvested,
total RNA isolated and viral gene expression determined by real-time
RT-PCR with KSHV ORF73 (a) and ORF50 (b) gene specific primers and
TaqMan probes. (c) Entry of KSHV in c-Cbl ShRNA transduced cells.
Untransduced, control shRNA and c-Cbl shRNA transduced HMVEC-d
cells were infected with KSHV for 30 min. DNA was isolated and KSHV
entry was determined by real-time DNA PCR for ORF73 gene. For all the
above, each reaction was done in duplicate and each bar represents the
average 6 SD of three experiments.
doi:10.1371/journal.ppat.1001238.g002
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PLoS Pathogens | www.plospathogens.org 5 December 2010 | Volume 6 | Issue 12 | e1001238Figure 3. c-Cbl associates with KSHV induced blebs. (a) Association of blebs with KSHV in the infected cells. HMVEC-d cells were infected with
KSHV for 5 min and immunostained with anti-gpK8.1A (viral envelope glycoprotein) antibody for the detection of KSHV. Images showing blebs were
acquired by fluorescence microscopy equipped with DIC (Differential Interference Contrast). The merged image represents a gpK8.1A, DIC, and DAPI
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decrease in the entry of KSHV. These results further suggested
that a c-Cbl containing signaling complex may be crucial for the
initiation of entry and for a productive infection.
KSHV infection utilizes blebbing as a mechanism of entry
in HMVEC-d cells
In our earlier studies we have demonstrated that macropino-
cytosis is the major pathway of KSHV entry leading to a
productive infection in HMVEC-d cells [4]. Since c-Cbl inhibited
KSHV’s entry, we theorized that c-Cbl might be playing a role in
macropinocytosis and associated signaling events. Viruses such as
vaccinia virus that use macropinocytosis as a mode of entry induce
signaling molecules and cytoskeletal rearrangements in the form of
blebs which ultimately retract and ingest viral particles [23,24]. To
determine whether blebs were involved in KSHV infection, we
used DIC image analysis and observed the association of KSHV
with blebs. As shown in Figure 3a, bleb formation and the
association of individual blebs with KSHV was observed by 5 min
p.i.. The DIC microscopic analysis of a single bleb for viral
particles confirmed that the blebs, formed during viral infection,
were associated with viral particles (Figure 3b). To further
investigate whether KSHV infection induces blebbing,
HMVEC-d cells were infected with KSHV for 2 and 5 min and
then actin, a well known determinant of cell shape and blebbing,
was stained with phalloidin [25]. Within 2 min of infection,
membrane protrusions appeared along the cell surface which
rapidly enlarged into well-formed blebs at 5 min (Figure S2). We
also observed the association of viral particles at the bleb forming
site as well as with retracting blebs (Figure S2). Unlike the well
formed blebs, the retracting blebs were characterized by a thick
actin cortex [26]. These results demonstrated that early during
infection, KSHV induces actin reorganization and the subsequent
formation of blebs that may be involved in its entry.
c-Cbl associates with KSHV induced membrane blebs
Since we observed that c-Cbl shRNA inhibited KSHV entry,
which involves bleb formation, we hypothesized that c-Cbl and its
phosphorylation might be involved in the dynamics of virus
induced blebbing. To understand the function of c-Cbl in
blebbing, we examined the localization of phosphorylated c-Cbl
(p-Cbl) in KSHV infected cells. Confocal microscopy analysis
showed that KSHV induced p-Cbl localized to blebs as early as
2 min p.i. (data not shown). Bleb formation, and its association
with p-Cbl, was maximal at 5 min, and by 10 min blebs
containing p-Cbl started internalizing and p-Cbl was mostly
observed at the nuclear periphery by 15 min p.i. (Figure 3c). A
similar pattern of localization was exhibited by p-Cbl and virus at
the blebs as early as 5 min p.i., and accumulation of p-Cbl and
virus around the nuclear periphery was observed at 15 min p.i.
(Figure 3d). These results suggested that the recruitment of
phosphorylated c-Cbl to the sites of bleb formation was involved in
bleb associated entry of the virus.
c-Cbl is essential for macropinocytosis of KSHV
To further explore the role of c-Cbl in bleb associated
macropinocytosis, we performed a confocal immunofluorescence
colocalization study between p-Cbl and the macropinocytosis
marker dextran in infected cells. This analysis showed that dextran
colocalized with p-Cbl at 10 min p.i. (Figure 4a) in the infected
cells. Next, we performed a dextran uptake study since the uptake
of dextran has been used as a biochemical marker of macro-
pinocytosis. We incubated the cells with dextran in the presence or
absence of virus for 30 min and then quantitated the level of
uptake. As shown in Figure 4b and supplementary information
Figure S3a, c-Cbl shRNA cells showed a drastic inhibition of
dextran uptake compared to control shRNA cells infected with
KSHV. This indicated that the uptake of dextran or macro-
pinocytosis in KSHV infected cells was a c-Cbl dependent process.
The uptake of dextran and colocalization with KSHV in non-
specific control shRNA and c-Cbl shRNA cells were confirmed by
immunofluorescence colocalization and DIC analysis. In control
shRNA cells infected with KSHV, intracellular KSHV was highly
colocalized with dextran, whereas in c-Cbl shRNA cells infected
with KSHV, most of the viral particles remained at the membrane
periphery although minimal colocalization of KSHV with dextran
was observed in some cells (Figure 4c and Figure S3b). Control
shRNA cells incubated with KSHV and Alexa 594 transferrin, a
marker for clathrin-mediated endocytosis, did not show any
significant colocalization with KSHV (Figure 4c and Figure S3b)
which demonstrated the specificity of macropinocytosis mediated
entry in HMVEC-d cells [4]. These results were consistent with
the results of the dextran uptake study, confirming that c-Cbl was
critical for inducing the macropinocytic process that promoted the
internalization of KSHV.
The uptake of dextran in control shRNA and c-Cbl shRNA cells
was further quantified by FACS analysis. Cells were incubated
with dextran in the presence or absence of virus for 30 min and
the uptake was measured using flow cytometry. As shown in
Figure 4d, compared to the control shRNA cells, c-Cbl shRNA
cells showed a notable decrease in mean fluorescence intensity.
These results are consistent with the results of the immunofluo-
rescence analysis and thus confirmed the role of c-Cbl in KSHV
induced macropinocytosis.
KSHV induces the interaction of c-Cbl with myosin IIA
c-Cbl is a multi-domain protein that interacts with a number of
signaling molecules and performs multiple functions [10,11]. To
decipher the molecular partners interacting with c-Cbl during
KSHV infection, we used mass spectrometric analysis. HMVEC-d
cells were infected with KSHV for 1, 5 and 10 min, lysed and the
lysates were immunoprecipitated with anti-c-Cbl antibodies.
Samples were separated by SDS-PAGE, followed by Coomassie
blue staining and mass spectrometry analysis. Mass spectrometry
identified several novel c-Cbl interacting proteins in the infected
samples (Supplementary Table S1). The most prominent protein
identified in the infected samples was myosin IIA which is one of
three isoforms of the non-muscle myosin II family of proteins
stained nucleus. Arrow heads indicate blebs and arrows indicate viral particles (gpK8.1A staining) associated with the blebs. Scale bar: 10 mm. (b) Image
of a single bleb and KSHV (gpK8.1A staining) were acquired by fluorescence microscopy equipped with DIC under an 100x objective lens. The gpK8.1A,
DIC and DAPI-stained nucleus are merged in the rightmost image. Arrow heads indicate a bleb and arrows indicate viral particles associated with the
bleb. (c) Association of blebs with c-Cbl in the infected cells. Uninfected or cells infected with KSHV for 5, 10 and 15 min were stained with rhodamine-
phalloidin and with anti-phospho c-Cbl (p-Cbl) antibody. The staining was analyzed by confocal microscopy sections through the z axis. Arrows indicate
the association of p-Cbl with blebs and internalization at different time points. Bottom and side bars represent the xz axis. The boxed areas are enlarged
in the rightmost panel. Scale bar: 10 mm. (d) Association of viral particles with c-Cbl in the infected cells. HMVEC-d cells infected with KSHV for 5, 10 and
15 min were fixed and processed for double immunofluorescence using anti-p-Cbl and anti-gpK8.1A antibodies. Panels show the staining of gpK8.1A,
and the images merged with p-Cbl, DAPI and DIC. Arrows indicate the colocalization of p-Cbl and gpK8.1A in the infected cells.
doi:10.1371/journal.ppat.1001238.g003
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PLoS Pathogens | www.plospathogens.org 7 December 2010 | Volume 6 | Issue 12 | e1001238Figure 4. c-Cbl is involved in macropinocytosis of KSHV. (a) Colocalization of c-Cbl with the macropinocytosis marker dextran. HMVEC-d cells
were incubated with medium containing Texas Red labeled dextran alone (no virus, UN) or with KSHV and Texas Red labeled dextran at 37uC for
10 min. Cells were processed for confocal immunofluorescence using anti-p-Cbl antibody and costained with DAPI. Arrows in the merged panel
indicate colocalization of p-Cbl with dextran. Scale bar: 10 mm. Bottom and side bars represent the xz axis. (b) Dextran uptake in c-Cbl shRNA cells.
Control shRNA or c-Cbl shRNA transduced HMVEC-d cells were incubated with KSHV and Texas Red labeled dextran or with Texas Red labeled dextran
alone (UN) at 37uC for 30 min. Quantitative analysis of dextran uptake was determined as described in the methods and represent the mean 6 SD of
three independent experiments. (c) Colocalization of dextran and KSHV. HMVEC-d cells transduced with control shRNA or c-Cbl shRNA were
incubated with KSHV and Texas Red labeled dextran for 30 min at 37uC. Control shRNA cells incubated with KSHV and Alexa 594 labeled transferrin
for 30 min were used as specificity controls. The cells were then stained with anti-gpK8.1A antibody and analyzed by fluorescence microscopy
combined with DIC. Merged panel shows the images merged with DAPI stained nuclei and DIC. The boxed areas are enlarged in the rightmost panel.
Arrows: colocalization of KSHV with dextran in the control shRNA cells. Arrow heads: viral particles remained at the cell membrane in c-Cbl shRNA
cells. Blocked arrows: non-colocalization of viral particles with transferrin in control shRNA cells. (d) Flow cytometry analysis of FITC-dextran uptake.
Control and c-Cbl shRNA cells were incubated with 500 mgm l
21 FITC-dextran in the presence or absence of virus at 37uC for 30 min. The cells were
then washed, harvested, fixed and analyzed by flow cytometry. Quantification of flow cytometry analysis of dextran uptake is shown as mean
fluorescence intensity.
doi:10.1371/journal.ppat.1001238.g004
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infected cells included vimentin, HSP70, BiP protein, Rho GEF
and a solute carrier anion exchanger (Table S1).
To confirm the mass spectrometry data, uninfected and KSHV
infected cell lysates were immunoprecipitated with anti-c-Cbl
antibody and blotted for the three isoforms of the non-muscle
myosin II family, IIA, IIB and IIC, with isoform specific
antibodies. Our results confirmed that c-Cbl interacts with myosin
IIA in the lysates of infected cells, whereas the other isoforms did
not show any interaction with c-Cbl (Figure 5a).
To elucidate the functional domain of c-Cbl involved in myosin
IIA interaction, a series of truncated and mutant constructs of c-
Cbl with HA epitope tags were used (Figure S4). Since HMVEC-d
cells are not easily transfectable, we used HeLa cells for this study.
HeLa cells were transfected with vector alone, Cbl wild-type, Cbl-
tyrosine kinase binding domain (TKB) mutant, RING domain
mutant, and two truncation mutants (Cbl-D357 and Cbl-D421). As
TPA (phorbol ester) has been shown to induce membrane
blebbing [29], we used TPA induced HeLa cells to analyze the
interaction of over-expressed c-Cbl with endogenous myosin IIA.
Transfection of the Cbl-TKB mutant and RING mutant induced
the interaction of c-Cbl with myosin IIA similar to full length
wild-type Cbl. The truncated versions Cbl-D357 and Cbl-D421
lacking a C-terminal proline rich domain (PRD) decreased
the interaction with myosin IIA considerably (Figure 5b).
Expression of all constructs determined by Western blotting with
HA revealed comparable levels of protein (Figure 5b). Taken
together, these results indicated that the C-terminal region
encompassing the PRD of c-Cbl was sufficient for association
with myosin IIA.
To further confirm that the C-terminal PRD of c-Cbl interacts
with myosin, an in vitro binding assay was performed using
bacterially expressed GST fusion proteins of c-Cbl C-terminal
(Cbl-C, encompassing PRD) and N-terminal (Cbl-N) domains.
GST Cbl-C and Cbl-N proteins adsorbed on glutathione
sepharose beads were incubated with 293T cell lysates expressing
GFP-tagged myosin IIA. The interaction between GFP-myosin
IIA and GST-Cbl was analyzed by Western blotting with anti-
GFP antibody. Our results demonstrated that myosin IIA
predominantly interacted with Cbl-C domains compared to Cbl-
N (Figure 5c).
Myosin II inhibitor reduces entry of KSHV
The interaction of myosin IIA with c-Cbl suggested that their
association could be playing a role in blebbing and macropino-
cytosis of KSHV. To investigate this, we used blebbistatin, a
specific inhibitor of myosin II ATPase activity that has been shown
to inhibit myosin II induced blebbing [30,31] and macropinocy-
tosis [23]. As shown in Figure 6a, we observed a dose dependent
inhibition of KSHV internalization in 25 mM( ,35%) and 50 mM
(,60%) concentrations of blebbistatin indicating that the entry
process was dependent on myosin II activity. As reported
previously [4], chlorpromazine, an inhibitor of clathrin dependent
endocytosis, did not show any notable decrease in entry of KSHV
(Figure 6a). These findings suggested that c-Cbl associated myosin
IIA was involved in bleb mediated macropinocytosis of KSHV.
To determine whether blebbistatin treatment affects other
internalization pathways, we investigated the effect of blebbistatin
on clathrin-mediated internalization, a major and well character-
ized endocytic pathway of eukaryotic cells. To study this,
untreated or blebbistatin treated HMVEC-d cells were induced
with FBS in the presence of Alexa 594 labelled transferrin or
Texas Red labelled dextran. The endocytic uptake of transferrin
and dextran were then analyzed using immunofluorescence. As
indicated in Figure 6b and d, blebbistatin strongly inhibited the
uptake of dextran, whereas the uptake of transferrin was
unaffected (Figure 6c and e). This demonstrated that blebbistatin
specifically inhibits macropinocytosis but not clathrin mediated
endocytosis pathways.
c-Cbl is upstream of myosin IIA in the induction of blebs
during KSHV infection
The above studies demonstrated that the c-Cbl interacting
partner myosin IIA is a biologically significant component of the c-
Cbl signaling pathway. We then explored the role of c-Cbl in
myosin II induced blebbing in KSHV infected cells. If c-Cbl is an
Figure 5. c-Cbl associates with myosin IIA in KSHV infected
cells. (a) c-Cbl co-immunoprecipitates with myosin IIA in KSHV infected
cells. Serum starved HMVEC-d cells were left uninfected (UN) or infected
with KSHV for 10 min. The cells were lysed, immunoprecipitated with
anti-c-Cbl antibody and Western blotted with myosin II isoform specific
antibodies, IIA, IIB and IIC. Bottom panel: loading control with anti-beta
actin antibody. (b) c-Cbl associates with endogenous myosin IIA in HeLa
cells. HeLa cells were transfected with HA-tagged empty vector or Cbl
wild-type, TKB mutant or RING mutant, truncated Cbl-D421 or Cbl-D357
constructs.CellswerestimulatedwithTPAfor5 minandtheresultingcell
lysates were subjected to immunoprecipitation with anti-HA antibodies
followed by immunoblotting with myosin IIA antibody (top). Western
blotting was carried out with anti-HA antibody using the same lysates
(bottom). (c) GST pull-down assay. GST Cbl-C and Cbl-N fusion proteins
expressed in bacterial cells were adsorbed with GST-beads at 4uCf o r2h .
The beads were washed and incubated with lysates of 293T cells
transiently expressing GFP-tagged myosin IIA. The proteins bound with
GST beads were analyzed by Western blotting with anti-GFP antibody.
Bottom panel shows GST expression with anti-GST antibody.
doi:10.1371/journal.ppat.1001238.g005
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should prevent the formation of myosin II mediated blebs in c-Cbl
shRNA cells. To test this hypothesis, control shRNA and c-Cbl
shRNA transduced HMVEC-d cells were infected with KSHV
and the percentage of cells with blebs was quantitated. As
expected, in c-Cbl shRNA transduced cells, the blebs were
considerably reduced compared to control shRNA cells (Figure 7a
and b). This suggested that c-Cbl and associated myosin IIA
molecules were linked to induce membrane blebbing in HMVEC-
d cells. Our results indicated that c-Cbl plays an upstream role in
the regulation of bleb formation which occurs as a result of myosin
II induced cortical contractility [25,26].
To further demonstrate that c-Cbl is upstream to myosin IIA,
we infected blebbistatin treated cells with KSHV and the
membrane localization of c-Cbl was observed by immunofluores-
cence. As shown in Figure 7c, blebbistatin did not inhibit the
localization of c-Cbl to the plasma membrane, whereas it
prevented the formation of blebs in the infected cells. This
suggested that myosin IIA was downstream to c-Cbl and was not
involved in the localization of c-Cbl to the plasma membrane.
Figure 6. Blebbistatin inhibits macropinocytosis of KSHV. (a) Effect of blebbistatin on entry of KSHV. HMVEC-d cells were pretreated with 25
and 50 mM blebbistatin (Bleb) or with 2.5 mgm l
21 chlorpromazine (Chlor) for 1 h before infection with KSHV for 30 min. The cells were then treated
with trypsin-EDTA, harvested, and total DNA was isolated. Entry was determined by estimating ORF73 DNA copies by real-time DNA PCR. Percentage
inhibition of KSHV DNA internalization was calculated compared to the untreated cells. (b and c). Effect of blebbistatin on dextran and transferrin
uptake. HMVEC-d cells were left untreated or treated with blebbistatin for 1 h at 37uC. The cells were then induced with FBS in the presence of
dextran (b) or transferrin (c) for 30 min, fixed and analyzed by immunofluorescence. (d and e) Quantitative analysis of dextran and transferrin uptake
was determined by counting the number of positive cells. At least 10 different microscopic fields of 50 cells each were counted for each experiment
and the results displayed as percentage of dextran or transferrin positive cells.
doi:10.1371/journal.ppat.1001238.g006
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chain II
A subclass of myosins, the class II myosins are hexameric motor
proteins composed of two identical heavy chains (MHC), and two
pairs of light chains (MLC). It has been well accepted that
phosphorylation of the myosin light chain II is a major
determinant of force generation and actomyosin dynamics during
apoptotic membrane blebbing [32,33]. Hence, we examined
phosphorylation of myosin light chain II (p-MLC II) during
KSHV infection. Compared to the uninfected cells, KSHV
infection results in rapid and strong phosphorylation of MLC II
with maximal phosphorylation at 10 min p.i. (5.8-fold increase)
and decreased thereafter (Figure 7d). The specificity of virus
induced MLC II phosphorylation was shown using heparin treated
virus which did not induce MLC II phosphorylation (Figure 7d).
Since light chain phosphorylation has been shown to regulate
blebbing [32,33], our results suggested that KSHV induced MLC
II may be participating in the induction of blebbing during
infection.
c-Cbl is required for the recruitment of myosin IIA to the
membrane blebs
During virus induced and apoptotic membrane blebbing, the
signaling molecules associated with cytoskeletal function are
recruited to the blebs [23,26]. It has been demonstrated that the
recruitment of functional myosin II heavy and light chain
complexes drive the process of bleb retraction [26]; however, it
is not clear how individual myosin II molecules are recruited to the
blebs. It is possible that c-Cbl interaction with myosin IIA leads to
recruitment of the complex to the blebs. Therefore, we infected
control shRNA and c-Cbl shRNA cells with KSHV and tested the
association of c-Cbl with myosin II in the blebs.
Punctate staining of p-Cbl and p-MLC II was observed in the
interior of blebs with a predominant colocalization between p-Cbl
and p-MLC II in control shRNA infected cells (Figure 8a)
suggesting that phosphorylated Cbl recruits individual myosin
molecules to the blebs. In contrast, c-Cbl shRNA cells infected
with KSHV did not show bleb formation and the recruitment and
localization of myosin II to the bleb membrane (Figure 8a).
Figure 7. c-Cbl is upstream of myosin IIA in the induction of blebs. (a) Effect of c-Cbl shRNA on KSHV induced blebbing. Control shRNA and
c-Cbl shRNA cells were infected with KSHV for 5 min. Uninfected and infected cells were fixed and the blebs were observed under an
immunofluorescence microscope with DIC. The percentage of blebbed cells was determined and represented as mean 6 SD of three independent
experiments. (b) Blebbing in control and c-Cbl shRNA transduced cells. Representative DIC images showing bleb formation in control and c-Cbl
shRNA cells infected with KSHV. Nuclei were stained with DAPI and merged with DIC images. KSHV induced blebs can be seen in control cells
(arrows), whereas bleb formation in c-Cbl shRNA cells is comparatively less. Scale bar: 10 mm. Insets show a single enlarged cell. (c) Blebbistatin does
not affect membrane localization of p-Cbl. HMVEC-d cells were pretreated with blebbistatin for 1 h at 37uC. Untreated and cells treated with
blebbistatin were infected with KSHV for 5 min, fixed and immunostained for p-Cbl. (d) KSHV induces phosphorylation of p-MLC II. Serum starved
HMVEC-d cells were left uninfected or infected with KSHV for 2, 10, 15 and 30 min. Cells infected with heparin treated (Hep) virus were used as
negative control. Cell lysates were Western blotted with anti-p-MLC II antibodies (top panel) or anti-b actin antibodies (bottom panel).
doi:10.1371/journal.ppat.1001238.g007
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and c-Cbl to the blebs, membrane fractions from control shRNA
infected cells and c-Cbl shRNA infected cells were isolated and
analyzed by Western blotting. Compared to the uninfected cells,
control shRNA cells infected with KSHV showed a 3.2 and 2.9-
fold increase in membrane localization of myosin IIA and c-Cbl,
respectively, whereas in c-Cbl shRNA-KSHV cells, membrane
localization of myosin IIA and c-Cbl was almost completely absent
(Figure 8b). This suggested that a decrease in membrane
localization of myosin IIA in c-Cbl shRNA cells may be caused
by a deficiency in the association of c-Cbl with myosin IIA.
Myosin II associates with actin in KSHV induced blebs
Myosin II molecules recruited to the membrane blebs form
contractile foci in association with actin under the bleb membrane
which is critical for bleb retraction [26]. Therefore, we asked
whether a similar kind of association occurs between p-MLC II
and actin in control shRNA-KSHV and c-Cbl shRNA-KSHV
Figure 8. c-Cbl recruits myosin IIA to the membrane blebs. (a) Colocalization of c-Cbl and p-MLC II in KSHV induced blebs. Control and c-Cbl
shRNA cells were infected with KSHV for 5 min. Uninfected and infected cells were then immunostained with anti-p-Cbl or anti-p-MLC II antibody. The
rightmost panels show DIC images. In the merged panel, arrows indicate the colocalization of p-Cbl with p-MLC II. Scale bar: 10 mm. (b) Membrane
association of myosin II in c-Cbl shRNA cells. Control shRNA and c-Cbl shRNA cells were infected with KSHV for 10 min. The membrane fractions were
isolated from uninfected and infected samples, then Western blotted with myosin IIA to analyze the membrane localization of myosin IIA (top). The
same membrane was stripped and reprobed with anti-c-Cbl to analyze the corresponding c-Cbl membrane localization (bottom).
doi:10.1371/journal.ppat.1001238.g008
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PLoS Pathogens | www.plospathogens.org 12 December 2010 | Volume 6 | Issue 12 | e1001238Figure 9. Myosin II associates with actin in KSHV induced blebs. (a) Colocalization of p-MLC II with actin in KSHV induced blebs. Control and
c-Cbl shRNA transduced cells were infected with KSHV for 5 min and stained with rhodamine-phalloidin and anti-p-MLC II antibody. Arrows indicate
the colocalization of p-MLC II and actin in the blebs. The rightmost column shows DIC images. Scale bar: 10 mm. (b) Actin inhibitor does not affect the
interaction of myosin IIA with c-Cbl. HMVEC-d cells were pretreated with 2 mgm l
21 cytochalasin D for 1 h at 37uC and then infected with KSHV and
washed. Cells were lysed and the cell lysates were immunoprecipitated with c-Cbl antibody and Western blotted with myosin IIA. (c) and (d)
Ubiquitination of myosin and actin. Control shRNA and c-Cbl shRNA cells were serum starved overnight and infected with KSHV for 10 min, and lysed.
Cell lysates were immunoprecipitated with anti-actin antibody (c) or anti-myosin antibody (d) and analyzed by Western blotting using anti-ubiquitin
antibody. Membranes were reprobed with actin or myosin antibody. Arrow marks indicate multiple bands of ubiquitinated proteins. To show the
multiple bands of ubiquitinated actin and myosin, actin (40 kDa) was resolved on a 12.5% gel (Figure 9c). Since myosin is a high molecular weight
protein (220 kDa), for better resolution, 7.5% gel was used (Figure 9d).
doi:10.1371/journal.ppat.1001238.g009
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association of actin and p-MLC II in the membrane blebs in
control shRNA KSHV infected cells (Figure 9a). Bleb formation
and the association of actin with p-MLC II in the blebs were not
seen in c-Cbl shRNA-KSHV cells (Figure 9a). The association of
p-MLC II with actin, which is a known interacting partner of c-
Cbl [10], coupled with the detection of an association with c-Cbl
in the infected cells (Table S1) suggested that actin, myosin IIA
and c-Cbl are part of a signaling complex which might be essential
for the formation of blebs and bleb retraction.
To examine whether the interaction of c-Cbl with myosin IIA is
actin dependent, we investigated the interaction of c-Cbl with myosin
IIA in cells treated with actin inhibitor cytochalasin D. The interaction
between c-Cbl and myosin IIA was then examined by coimmunopre-
cipitation and Western blot analysis. As shown in Figure 9b,
cytochalasin D did not inhibit the interaction of myosin IIA with c-
Cbl. The interaction of myosin IIA with c-Cbl in cytochalasin D
treated cells suggested that actin is not essential for the initial association
of myosin IIA with c-Cbl in KSHV infected cellular environment.
c-Cbl is an E3 ubiquitin ligase, which has been shown to be
involved in poly or monoubiquitination of a number of proteins
[34,35,36]. To further analyze the functional significance of the
interaction between c-Cbl, myosin and actin, the role of c-Cbl in
ubiquitination of actin and myosin was analyzed. Both myosin and
actin ubiquitination were determined in control shRNA and c-Cbl
shRNA cells infected with KSHV. We observed multiple bands of
ubiquitinated myosin and actin probably indicating monoubiqui-
tination on multiple sites and not polyubiquitination in the infected
cells (Figure 9c and d). c-Cbl shRNA abolished the KSHV induced
ubiquitination of actin and myosin suggesting that it was mediated
by c-Cbl. This indicated that upon KSHV infection, c-Cbl binds
to actin and myosin which in turn is responsible for ubiquitination.
Discussion
Several viruses utilize macropinocytosis to gain access to target
cells [24]. Macropinocytosis is strictly an actin driven process
which includes the formation of membrane ruffles, lamellipodia
and blebs [24]. Blebbing is a phenomenon which is mainly
observed during cellular processes such as embryogenesis,
cytokinesis and apoptotic cell death [25]. Bleb associated
macropinocytosis provides a mechanism of virus entry into host
target cells and has been shown to be an efficient tactic of the virus
to enter the target cells by mimicking the apoptotic cells [23].
Macropinocytosis has been observed as a major route of entry of
KSHV into HMVEC-d cells, the natural target cells of infection
[3,4]. During KSHV infection, the interaction of KSHV glycopro-
teins with integrins and other cellular receptors activate host cell
signaling molecules FAK, Src, PI3-K, RhoA GTPase and are all
recruited to the entry site [3]. The inhibition of any of these proteins
significantly reduces the entry of virus suggesting that KSHV
exploits preexisting host cell signaling machinery for a successful
infection [3]. Our current study shows that c-Cbl is also required for
efficient macropinocytic uptake, suggesting that the previously
observed signaling molecules are linked via c-Cbl to perform their
downstream functions. Since bleb associated macropinocytosis is an
actomyosin dependent process, c-Cbl and its interaction with
myosin playing a role in macropinocytosis further strengthens the
possibility that c-Cbl is a critical molecule involved in linking the
signaling molecules in the virus induced macropinocytic process.
Based on the strong evidences presented here, we propose that
efficient bleb mediated macropinocytic uptake enables a productive
infection of KSHV to occur in cells supporting a signaling cascade
that contains the c-Cbl-myosin IIA complex, and that a defect in c-
Cbl-myosin IIA association results in lowered macropinocytic
Figure 10. Model depicting the role of c-Cbl and myosin IIA interaction during blebbing and macropinocytosis of KSHV. KSHV has
been previously shown to interact with heparin sulfate, a3b1, aVb3 and aVb5 integrins and xCT molecules leading to the phosphorylation of FAK and
the downstream molecules such as Src, PI3-K and RhoGTPases [3]. KSHV infection induces the phosphorylation of c-Cbl and the phosphorylated c-Cbl
forms a complex with p85-PI3K, thus facilitating the interaction of c-Cbl with downstream molecules. c-Cbl associates with myosin IIA and actin and is
rapidly recruited to membrane blebs. This association also leads into c-Cbl mediated ubiquitination of actin and myosin. Myosin IIA interactions with
actin may be accelerating the actomyosin contraction and bleb retraction which form macropinosomes along with the viral particles. Myosins
probably provide the ATP-dependent force to generate the movement required for the process of bleb retraction. An increase in c-Cbl–myosin IIA
association possibly affects c-Cbl-mediated blebbing, macropinocytosis and internalization of KSHV.
doi:10.1371/journal.ppat.1001238.g010
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macropinocytic uptake and blebbing by blebbistatin treatment
and c-Cbl silencing with shRNA strongly suggests that bleb
associated macropinocytosis is the predominant pathway of KSHV
infection in HMVEC-d cells. The defect in macropinocytosis in c-
Cbl shRNA cells could be due to a defect in linking myosin II
molecules to the membrane associated events which is necessary for
blebbing and bleb mediated macropinocytosis [24,25,26].
Although the molecular details of bleb associated macropino-
some formation are yet to be uncovered, our study demonstrates
that during KSHV infection, the interaction of c-Cbl with myosin
IIA leads to bleb formation and the recruitment of myosin IIA into
the blebs, where the myosin IIA molecules could be interacting
with actin to accelerate actomyosin contraction and bleb
retraction [26]. Retracting blebs form macropinosomes along
with the viral particles close to the blebs (Figure 10) [24]. Myosins
provide the ATP-dependent force to generate the movement
required for the process of bleb retraction [26]. Myosin IIA is the
major isoform of myosin II implicated in membrane associated
functions such as the maintenance of cell shape and movement
[37,38]. The functional ending of ubiquitination is related to the
type of ubiquitin chains added to the substrate protein [39].
Monoubiquitination promotes internalization of cell surface
receptors and subsequent lysosomal degradation [40], whereas
polyubiquitinated proteins are targeted for proteasomal degrada-
tion [41]. Whether the complex events associated with the
monoubiquitination of actin and myosin by c-Cbl could be related
to an increase in the activity of actomyosin contraction or directing
subcellular compartmentalization during KSHV infection and
macropinocytosis remains to be studied in detail. Further studies
are required to understand the molecular aspects of the interaction
between c-Cbl and myosin IIA and their role in subsequent stages
of bleb mediated macropinocytosis. Further studies are also
required to validate the specificity and the functional significance
of other identified c-Cbl interacting proteins, their association with
c-Cbl during infection and whether c-Cbl induces the ubiquitina-
tion of cell surface molecules recognized by KSHV.
In conclusion, our results provide for the first time clear evidence
demonstrating that c-Cbl, and the interaction between c-Cbl and
myosin IIA, is critical for triggering bleb mediated macropinocytic
events during KSHV entry into target cells (Figure 10). This study
also provides the first evidence that c-Cbl and a c-Cbl mediated
signaling pathway as well as ubiquitination play roles in viral
infection and that c-Cbl function as an adaptor protein for PI3-K
andotherKSHVinducedsignalingevents.Thisalsoidentifiesc-Cbl
as a potential target to intervene in KSHV infection.
Supporting Information
Figure S1 (a) shRNA transduction. HMVEC-d cells transduced
with c-Cbl shRNA lentivirus or with non-targeting control shRNA
lentivirus were selected using puromycin hydrochloride. Western
blotting with anti c-Cbl antibody showed 90% knockdown of
endogenous c-Cbl expression in c-Cbl shRNA transduced cells. (b
and c) Histograms depict KSHV ORF73 (b) and ORF50 (c) gene
RNA copy numbers in untransduced, control shRNA and c-Cbl
shRNA transduced cells. Each reaction was done in duplicate, and
each bar represents the mean 6 SD of the results of three
independent experiments. (d) Histogram shows KSHV internal-
ized viral ORF73 DNA copy numbers in untransduced, control
shRNA and c-Cbl shRNA transduced cells. Each reaction was
done in duplicate, and each bar represents the mean 6 SD of
three experiments.
Found at: doi:10.1371/journal.ppat.1001238.s001 (0.29 MB
TIF)
Figure S2 Actin reorganization and blebbing in KSHV infected
cells. HMVEC-d cells were either left uninfected or infected with
KSHV for 2 or 5 min, stained with rhodamine-phalloidin for
filamentous actin and anti-gB (viral glycoprotein) antibody for the
detection of KSHV. Arrows indicate viral particles stained with
gB; arrow heads indicate blebs formed (devoid of an actin cortex)
during KSHV infection; blocked arrows indicate a retracting bleb
(with thick actin cortex) with viral particles. Scale bar: 10 mM. The
boxed areas are enlarged in the rightmost column.
Found at: doi:10.1371/journal.ppat.1001238.s002 (1.74 MB
TIF)
Figure S3 Uptake and colocalization of dextran with KSHV. (a)
Representative immunofluorescence image for figure 4b showing
dextran uptake in uninfected and infected control and c-Cbl
shRNA cells. Dextran positive cells are merged wth DAPI in the
merged panel. (b) Immunofluorescence image of a microscopic
field of view showing dextran uptake and colocalization with
KSHV in control and c-Cbl shRNA cells. Right- most panels show
enlarged single cell from each panel. Dashed lines represent the
cell periphery. Arrows indicate uptake and colocalization of
dextran and KSHV in control cells; arrowheads indicate viral
particles that remained at the cell periphery in c-Cbl shRNA cells;
blocked arrows indicate non colocalization of transferrin and
KSHV in control cells.
Found at: doi:10.1371/journal.ppat.1001238.s003 (1.90 MB
TIF)
Figure S4 Schematic illustration of HA tagged Cbl wild-type,
Cbl-TKB mutant (which lacks a functional TKB domain), Cbl-
RING mutant (which lacks ubiquitin ligase activity of the RING
domain), and two truncation mutants Cbl-D357 and Cbl-D421
(which lacks the C-terminal proline rich domain as well as the
UBA and LZ domain).
Found at: doi:10.1371/journal.ppat.1001238.s004 (0.12 MB TIF)
Table S1 Mass spectrometry analysis of c-Cbl interacting
proteins in the infected samples. c-Cbl interacting proteins
identified in mass spectrometry analysis. Serum starved
HMVEC-d cells were left uninfected or infected with KSHV for
1, 5, 10 min, and the cell lysates were immunoprecipitated with
anti-c-Cbl antibody. Immunoprecipitated proteins were separated
by SDS-PAGE gel and the gel slices were analyzed by mass
spectrometry. The table shows a list of proteins identified by mass
spectrometry. The score (%) and coverage (%) obtained for each
protein are also indicated.
Found at: doi:10.1371/journal.ppat.1001238.s005 (0.05 MB RTF)
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